J. David Enloe, Jr. has been appointed president and chief executive officer of Ajinomoto Althea Inc. Mr. Enloe will be responsible for developing strategies to support the company’s growth efforts.   Mr. Enloe has more than 20 years of executive management experience, primarily in biotechnology, drug development, and GMP manufacturing. Most recently, he served as head of the Viral Therapeutics Business Unit at Lonza AG, which provides process development, scale-up and GMP manufacture of v...